{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:19:42Z","timestamp":1790936382068,"version":"4.1.0"},"reference-count":34,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2000,12,1]]},"abstract":"<jats:p> PURPOSE: To investigate the use of a nonmyeloablative fludarabine-based immunosuppressive regimen to allow engraftment of HLA-sibling donors\u2019 mobilized stem cells and induction of a graft-versus-lymphoma effect for patients with advanced resistant Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. <\/jats:p><jats:p> PATIENTS AND METHODS: Fifteen patients with Hodgkin\u2019s disease (n = 10) and non-Hodgkin\u2019s lymphoma (n = 5) were studied. All patients received cyclophosphamide and granulocyte colony-stimulating factor to mobilize autologous hematopoietic stem cells (HSCs). Subsequently, they received high-dose therapy with carmustine, etoposide, cytarabine, and melphalan and reinfusion of HSCs. At a median of 61 days after engraftment, patients were given fludarabine 30 mg\/m<jats:sup>2<\/jats:sup> with cyclophosphamide 300 mg\/m<jats:sup>2<\/jats:sup> daily for 3 days. Donor-mobilized HSC collections were prepared for fresh infusion and were not T-cell depleted. Methotrexate and cyclosporine were used to prevent graft rejection and as graft-versus-host disease (GVHD) prophylaxis. <\/jats:p><jats:p> RESULTS: Combined treatment was well tolerated. After mini-allografting, hematologic recovery was prompt. Thirteen patients had 100% donor cell engraftment. Eleven patients achieved complete remission (CR) after the combined procedure. Nine patients, who were in partial remission after autografting, achieved CR after mini-allografting. Seven patients developed \u2265 grade 2 acute GVHD (aGVHD) and two developed extensive chronic GVHD (cGVHD). Three patients who received the highest number of donor lymphocyte infusions (DLIs) developed grade 3 GVHD (two patients) and extensive cGVHD (one patient). Ten patients are currently alive, and five are in continuous CR. Seven patients received DLI, with five CRs. Five patients died: one of progressive disease, two of progressive disease combined with aGVHD or cGVHD, one of extensive cGVHD, and one of infection. <\/jats:p><jats:p> CONCLUSION: Fludarabine\/cyclophosphamide was well tolerated and allowed consistent engraftment in lymphoma allografted patients. Response rates were high in this group of refractory and heavily pretreated patients. This dual procedure seems to be most promising in patients with end-stage malignant lymphomas. <\/jats:p>","DOI":"10.1200\/jco.2000.18.23.3918","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:57:30Z","timestamp":1487919450000},"page":"3918-3924","source":"Crossref","is-referenced-by-count":188,"title":["Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin\u2019s Disease and Non-Hodgkin\u2019s Lymphoma"],"prefix":"10.1200","volume":"18","author":[{"given":"Angelo M.","family":"Carella","sequence":"first","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavaliere","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Lerma","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Ferrara","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Romanelli","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vinci","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Pinotti","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lambelet","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Loni","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Verdiani","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Stefano","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Valbonesi","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Corsetti","sequence":"additional","affiliation":[{"name":"From the Hematology and Autologous Stem Cell Transplantation Unit, Department of Hematology, Azienda Ospedale San Martino; Istituto Medicina Legale, Universit\u00e0 di Genova, Genova; Centro Trasfusionale, Ospedale San Martino, Genova; Oncologia Medica, Ospedale San Carlo, Milano; Oncologia Medica, Ospedale Circolo di Varese, Varese; and Divisione Medicina, Ospedale Pietrasanta, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1291"},{"key":"R2-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.12.2342"},{"key":"R3-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.527"},{"key":"R4-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.572"},{"key":"R5-0537","doi-asserted-by":"crossref","unstructured":"Jones  RJ,   Ambinder  RF,   Piantadosi  S,  et al:  Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.   Blood 3:  649,1991-653,","DOI":"10.1182\/blood.V77.3.649.bloodjournal773649"},{"key":"R6-0537","doi-asserted-by":"crossref","unstructured":"Chopra  R,   Goldstone  AH,   Pearce  R,  et al:  Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma:   A case-controlled analysis of the European Bone Marrow Transplant Group registry data.   J Clin Oncol 11:  1690,1992-1695,","DOI":"10.1200\/JCO.1992.10.11.1690"},{"key":"R7-0537","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89488-0"},{"key":"R8-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1050.1050"},{"key":"R9-0537","unstructured":"Appelbaum  FR:   Treatment of aggressive non-Hodgkin\u2019s lymphoma with marrow transplantation.   Marrow Transplant Rev 3:  1,1993-16,"},{"key":"R10-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.4201"},{"key":"R11-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.12.4531"},{"key":"R12-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.3.756"},{"key":"R13-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2817"},{"key":"R15-0537","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11135-2"},{"key":"R16-0537","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702204"},{"key":"R17-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.9.3234"},{"key":"R18-0537","unstructured":"Landman-Parker  J,   Socie  G,   Petit  T,  et al:  Detection of recipient cells after non T cell depleted marrow transplantation for leukemia by the PCR amplification of minisatellites or a Y chromosome marker has a different prognostic value.   Leukemia 8:  1989,1994-1993,"},{"key":"R19-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.12.3235.3235"},{"key":"R20-0537","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"R22-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.5.1137.1137"},{"key":"R23-0537","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058662"},{"key":"R24-0537","unstructured":"Wheeler  C,   Eickhoff  C,   Elias  A:   High-dose carmustine cyclophosphamide and etoposide with autologous transplantation in Hodgkin\u2019s disease:   A prognostic model for treatment outcome.   Biol Blood Marrow Transplant 3:  98,1997-106,"},{"key":"R25-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.5.1381.bloodjournal8551381"},{"key":"R26-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.704"},{"key":"R27-0537","unstructured":"Burns  LJ,   Daniels  KA,   McGlave  PB,  et al:  Autologous stem cell transplantation for refractory and relapsed Hodgkin\u2019s disease:   Factors predictive of prolonged survival.   Bone Marrow Transplant 16:  13,1995-18,"},{"key":"R28-0537","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.5.1193.1193"},{"key":"R29-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.9.1411"},{"key":"R30-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.12.2351"},{"key":"R31-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1062"},{"key":"R32-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3101"},{"key":"R33-0537","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.5.1096"},{"key":"R34-0537","unstructured":"Petersen  FB,   Appelbaum  FR,   Bigelow  CL,  et al:  High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.   Bone Marrow Transplant 4:  483,1989-488,"},{"key":"R35-0537","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700781"},{"key":"R37-0537","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60328-5"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2000.18.23.3918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:37:20Z","timestamp":1653514640000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2000.18.23.3918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2000,12,1]]}},"alternative-id":["10.1200\/JCO.2000.18.23.3918"],"URL":"https:\/\/doi.org\/10.1200\/jco.2000.18.23.3918","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12,1]]}}}